RESEARCH-FOCUSED. QUALITY-DRIVEN. GLOBAL FAST FULFILLMENT AVAILABLE.
Price range: $150.00 through $1,200.00
Buy 30mg Tirzepatide for high-throughput in-vitro cellular research. Independently tested research reagent for metabolic assays and receptor kinetics in laboratory settings.
Tirzepatide (30mg) provides an expanded quantity of high-purity dual GIP/GLP-1 receptor agonist peptide, specifically designed for high-throughput screening and long-term in-vitro cell culture projects. By acting simultaneously on both GIP and GLP-1 receptors, this compound provides essential data for evaluating synergistic receptor activation and signal transduction in metabolic models.
The 30mg unit allows research laboratories to prepare larger stock solutions, ensuring consistent reagent concentrations across multi-well assays and extended longitudinal cell studies without introducing batch-to-batch variance. It is widely utilized in scientific inquiry into cellular glucagon modulation, insulin secretion mechanics in cell lines, and receptor desensitization kinetics.
Application: High-throughput in-vitro screening, multi-plate cellular assays, and extended signal transduction studies.
Target: Dual agonist for GIP and GLP-1 receptors.
Quantity: 30mg lyophilized peptide per vial.
Purity Standard: Analytical grade chemical compound independently tested via HPLC and MS.
| Vial Quantity | Pack of 10 Vials ( Save 20% ), Pack of 5 vials ( Save 10% ), Single Vial |
|---|
Reviews
There are no reviews yet.